Taiho Pharmaceutical Company Ltd.
47 articles about Taiho Pharmaceutical Company Ltd.
-
Makoto Life Sciences, Inc. Signs $20 Million Research Collaboration With Taiho Pharmaceutical
8/2/2006
-
Taiho Pharmaceutical And Sanofi-Aventis (France) Conclude Licensing Agreement For Oral Pyrimidine Fluoride-Derived Anticancer Agent TS-1
7/10/2006
-
The Day In Review: Sanofi-Aventis (France) In-Licenses Japanese Cancer Drug
7/5/2006
-
Sanofi-Aventis (France) To Pay $360 Million To Japan's Taiho Pharmaceutical To License S-1 Oral Anticancer Agent
7/5/2006
-
AT&T Builds Nationwide Network For Taiho Pharmaceutical
5/24/2006
-
Taiho Pharmaceutical Licensed To Develop And Sell ABRAXANE Anti-Cancer Agent By American BioScience, Inc.
11/21/2005
-
American BioScience, Inc. Licenses ABRAXANE(TM) To Taiho Pharmaceutical, One Of The Largest Oncology Companies In Japan
11/16/2005